Emgality Prices, Coupons and Patient Assistance Programs
Emgality (galcanezumab) is a member of the CGRP inhibitors drug class and is commonly used for Cluster Headaches, and Migraine Prevention.
The cost for Emgality subcutaneous solution (gnlm 120 mg/mL) is around $725 for a supply of 1 milliliter(s), depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Emgality prices
Subcutaneous Solution
Quantity | Per unit | Price |
---|---|---|
3 (3 x 1 milliliters) | $599.16 | $1,797.49 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Quantity | Per unit | Price |
---|---|---|
1 milliliter | $724.70 | $724.70 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Emgality Coupons, Copay Cards and Rebates
Emgality offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Emgality Savings Card
Eligible commercially insured patients may pay $0 per 30-day supply; maximum annual savings of $4900; card expires at the end of each calendar year; for additional information contact the program at 833-364-2548.
- Applies to:
- Emgality
- Number of uses:
- 12 times within calendar year
Form more information phone: 833-364-2548 or Visit website
Emgality Savings Card
Eligible commercially insured patients/RX not covered pay as little as $0 for their first fill of a 30-day supply; for additional information contact the program at 833-364-2548.
- Applies to:
- Emgality
- Number of uses:
- Contact the program
Form more information phone: 833-364-2548 or Visit website
Patient Assistance & Copay Programs for Emgality
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Emgality Free Sharps Container Program
Eligibility requirements:- Not applicable
- Not applicable
- Not specified
- The patient must also be residing in the US.
- Patient enrolls to receive a free sharps container; Contact program for details: www.Emgality.com
- Emgality (container for emgality) Disposal Container
More information please phone: 800-545-5979 or 833-364-2548 Visit Website
Provider: Lilly Cares Foundation Patient Assistance Program
Eligibility requirements:- Contact program for details.
- Varies
- Not specified
- Must be US citizen or a legal permanent resident of the US
- Please visit www.LillyCares.com or call (800) 545-6962 for more information. Additional products may be available. Please contact the program for a complete product listing. Lilly donates products to the Lilly Cares Foundation Patient Assistance Program.
- Emgality (galcanezumab-gnlm) Injection
More information please phone: 800-545-6962 Visit Website
More about Emgality (galcanezumab)
- Check interactions
- Compare alternatives
- Reviews (440)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: CGRP inhibitors
- Breastfeeding